MedTrace Logo

Pulmonic SAPIEN S3™ THV Registry

NCT02777892 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2023-09-13

No results posted yet for this study

Summary

Multi-center, Observational Registry with Retrospective Enrollment and Prospective Follow-up.

The aim of the registry is to document the feasibility and safety of implanting an Edwards SAPIEN S3 transcatheter heart valve in the pulmonic position

Conditions

  • Pulmonary Valve Malfunction
  • Right Ventricular Outflow Tract (RVOT) Dysfunction

Interventions

OTHER

Sapien S3

Patients that have undergone percutaneous implantation of an Edwards SAPIEN S3 Transcatheter Heart Valve in the pulmonic position at the time of data collection

Sponsors & Collaborators

  • Institut für Pharmakologie und Präventive Medizin

    lead NETWORK

Principal Investigators

  • Peter Bramlage, Prof MD · Institut für Pharmakologie und Präventive Medizin

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2023-03-31
Completion
2023-07-31

Countries

  • Canada
  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02777892 on ClinicalTrials.gov